Larimar Therapeutics (LRMR) Other Non Operating Income (2013 - 2020)
Larimar Therapeutics (LRMR) posted Other Non Operating Income of $218000.0 for Q1 2020, up 282.46% on a QoQ basis from $57000.0 in Q4 2019, and up 847.83% year-over-year from $23000.0 in Q2 2019.
Larimar Therapeutics (LRMR) Other Non Operating Income (2013 - 2020) Analysis & Trends
Larimar Therapeutics' Other Non Operating Income history runs 8 years deep, the most recent figure standing at $218000.0 for Q1 2020.
- Quarterly Other Non Operating Income rose 847.83% year-over-year to $218000.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $220000.0 (up 245.7% YoY) and the FY2019 annual result came in at $25000.0, up 110.55% from the prior year.
- Other Non Operating Income was $218000.0 for Q1 2020 at Larimar Therapeutics, up from $57000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $218000.0 in Q1 2020 and bottomed at -$97000.0 in Q4 2016.
- A 5-year average of $7529.4 and a median of -$5000.0 in 2017 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2016 — Other Non Operating Income sank 1375.0% — and 2020, when it soared 847.83%.
- Larimar Therapeutics' Other Non Operating Income stood at -$97000.0 in 2016, then soared by 125.77% to $25000.0 in 2017, then tumbled by 320.0% to -$55000.0 in 2018, then soared by 203.64% to $57000.0 in 2019, then surged by 282.46% to $218000.0 in 2020.
- Business Quant data shows LRMR's Other Non Operating Income at $218000.0 in Q1 2020, $57000.0 in Q4 2019, and -$33000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 218,000.00 |
| Dec 31, 2019 | 57,000.00 |
| Sep 30, 2019 | -33,000.00 |
| Jun 30, 2019 | -22,000.00 |
| Mar 31, 2019 | 23,000.00 |
| Dec 31, 2018 | -55,000.00 |
| Sep 30, 2018 | -46,000.00 |
| Jun 30, 2018 | -73,000.00 |
| Mar 31, 2018 | -63,000.00 |
| Dec 31, 2017 | 25,000.00 |
| Sep 30, 2017 | 20,000.00 |
| Jun 30, 2017 | -5,000.00 |
| Mar 31, 2017 | 100,000.00 |
| Dec 31, 2016 | -97,000.00 |
| Sep 30, 2016 | 58,000.00 |
| Jun 30, 2016 | -51,000.00 |
| Mar 31, 2016 | 72,000.00 |
| Dec 31, 2015 | 59,000.00 |
| Sep 30, 2015 | -110,000.00 |
| Jun 30, 2015 | 4,000.00 |